87 Results
Guidelines and Advice
Status: Current
ID: GL-C50-29
ID: GL-C50-29
Mar 2012
Cancer facts
Cancer facts
Guidelines and Advice
Status: Current
Dec 2012
Guidelines and Advice
Status: Education and Information
Dec 2012
Drug
Aug 2025
Drug
Aug 2025
Drug

Updated
Aug 2025
Drug
Aug 2025
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™

Updated
Aug 2025
Drug

Updated
Aug 2025
Drug

Updated
Aug 2025